AQST FY 2019 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$53M-22.0% YoY

Gross Profit

$32M61.3% margin

Operating Income

-$53M-100.1% margin

Net Income

-$66M-125.9% margin

EPS (Diluted)

$-2.87

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$61M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$78M

Total Liabilities

$85M

Stockholders' Equity

-$6M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$67M	-22.0%
Gross Profit	$32M	$46M	-30.6%
Operating Income	-$53M	-$49M	-7.6%
Net Income	-$66M	-$61M	-7.9%